​​​​​In this episode, Andrew Halayko, PhD, ATSF, summarizes hot topics to be discussed at the American Thoracic Society (ATS) 2022 annual conference, including how COVID-19 has influenced the program agenda and highly anticipated keynote, clinical, and research sessions.

In this episode, Dr Rizzo interviews Geoffrey Chupp, MD, on his team’s research titled "Bronchial Thermoplasty in Patients with Severe Asthma at 5 years: Post-FDA Approval Clinical Trial Evaluating Bronchial Thermoplasty in Severe Persistent Asthma Study." Dr Chupp speaks about the efficacy, safety results, challenges, and controversies of the therapy.

​​​​​​In part 2 of this 2-part episode, James Matera, DO, FACOI, speaks about the infrastructure required for urgent-start peritoneal dialysis (PD) and the urgent-start PD clinical pathway from patient presentation to discharge home.

​​​​​​In part 1 of this 2-part episode, James Matera, DO, FACOI, speaks about the role, benefits, and challenges of urgent-start peritoneal dialysis in adults and children with chronic kidney disease requiring long-term kidney replacement therapy.

In part 2 of this 2-part episode, Dan Martin, MD, speaks about his team's research titled "The Epidemiology of Endometriosis is Poorly Known as the Pathophysiology and Diagnosis are Unclear," including the gaps in endometriosis research, why those gaps are so problematic, and the key takeaways from their research.

In part 1 of this 2-part episode, Dan Martin, MD, speaks about his team's research titled "The Epidemiology of Endometriosis is Poorly Known as the Pathophysiology and Diagnosis are Unclear," including the risk factors of endometriosis.

Episode 2: In this episode, Dr Rizzo speaks with Freda Patterson, PhD; Heather Bittner Fagan, MD, MPH; and Denise Taylor, MS, RD, regarding novel clinical interventions in cardiovascular disease, including sleep quality and smoking behavior. They also speak about the messaging around smoking cessation.

In this podcast, Georg Schett, MD, discusses the results and implications of his team’s recent study examining the tapering or stopping of medication in patients with rheumatoid arthritis who achieve stable remission.

In this podcast, Dr Schaffner discusses new data from the Centers for Disease Control and Prevention that suggest COVID-19 infections are close to 140 million. He also discusses the focus for the upcoming National Foundation for Infectious Diseases Annual Conference on Vaccinology Research taking place virtually on April 11 and April 12, 2022.

In this episode, Dr Singh interviews Meilan Han, MD, MS, University of Michigan (Ann Arbor, MI) and Jean Wright, MD, MBA, formerly Atrium Health (Charlotte, NC) on the management of COPD, including recent updates to COPD treatment guidelines, increasing public awareness, and diagnosing the disease early.